Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach

The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD) subtyping field and develop a guidance on future research in PD subtypes. Based on a literature review, we previously concluded that PD subtyp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Movement disorders Ročník 39; číslo 3; s. 462 - 471
Hlavní autoři: Marras, Connie, Fereshtehnejad, Seyed‐Mohammad, Berg, Daniela, Bohnen, Nicolaas I., Dujardin, Kathy, Erro, Roberto, Espay, Alberto J., Halliday, Glenda, Van Hilten, Jacobus J., Hu, Michele T., Jeon, Beomseok, Klein, Christine, Leentjens, Albert F.G., Mollenhauer, Brit, Postuma, Ronald B., Rodríguez‐Violante, Mayela, Simuni, Tanya, Weintraub, Daniel, Lawton, Michael, Mestre, Tiago A.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Hoboken, USA John Wiley & Sons, Inc 01.03.2024
Wiley Subscription Services, Inc
Wiley
Edice:Movement Disorders
Témata:
Clinical trials
heterogeneity
Life Sciences
Literature reviews
Movement disorders
Neurodegenerative diseases
Parkinson's disease
Precision medicine
purpose
subtypes
Therapeutic targets
Parkinson's disease
purpose
heterogeneity
subtypes
ISSN:0885-3185, 1531-8257, 1531-8257
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD) subtyping field and develop a guidance on future research in PD subtypes. Based on a literature review, we previously concluded that PD subtyping requires an ultimate alignment with principles of precision medicine, and consequently novel approaches were needed to describe heterogeneity at the individual patient level. In this manuscript, we present a novel purpose‐driven framework for subtype research as a guidance to clinicians and researchers when proposing to develop, evaluate, or use PD subtypes. Using a formal consensus methodology, we determined that the key purposes of PD subtyping are: (1) to predict disease progression, for both the development of therapies (use in clinical trials) and prognosis counseling, (2) to predict response to treatments, and (3) to identify therapeutic targets for disease modification. For each purpose, we describe the desired product and the research required for its development. Given the current state of knowledge and data resources, we see purpose‐driven subtyping as a pragmatic and necessary step on the way to precision medicine. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0885-3185
1531-8257
1531-8257
DOI:10.1002/mds.29708